Global SarcomaBiopsy Market, by Product Type (Reusable Device and Disposable Devices), byEnd User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), andby Region (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica), was valued at US$ 192.55 million in 2019, and is expected to exhibit a CAGR of 2.8% over theforecast period (2020-2027), as highlighted in a new report published byCoherent Market Insights.
Global sarcoma biopsy market isexpected to witness to significant growth during the forecast period, owing toincreasing technological advancements in the field of biopsy. For instance, inNovember 2015, Cook Medical launched its new EchoTip ProCore 20 gage needlewith ReCoil Stylet, which will help the physicians to collect the blood samplesfrom the rom difficult anatomical locations. Ecotip ProCore has core-traptechnology, which will allow the physicians to collect samples during theminimally invasive procedure.
Furthermore, in October 2017,European Commission approved the acquisition of C.R Bard by Becton DickinsonCompany. This acquisition helped the company to manufacture new medical devicesand technology, which will be utilized to cure many serious conditions such ascancer.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3819
Browse 26 Market Data Tables and25 Figures spread through 151 Pages and in-depth TOC on Global Sarcoma BiopsyMarket, by Product Type (Reusable Device and Disposable Devices), by End User(Hospitals, Ambulatory Surgical Centers, and Clinics), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa)-Forecast to 2027"
Increasing prevalence ofosteosarcoma is expected to drive growth of the global sarcoma biopsy market.
Osteosarcoma is the most commontype of cancer affecting bones, and it mostly occurs in children and youngadults. On the basis of cells, osteosarcoma is classified as high-,intermediate- and low-grade. For instance, according to the American CancerSociety, IN January 2020, around 800 to 900 new cases of osteosarcoma arediagnosed in the U.S. each year, with around 50% occurs in children andteenagers.
Global Sarcoma Biopsy Market–Regional Analysis
North America accounted for thelargest market share in the global sarcoma biopsy market, owing to risinghealthcare expenditure in the U.S. For instance, according to the Committee fora Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion,or 18% of the total GDP, on health expenditures, which is more than twice theaverage among developed countries.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/sarcoma-biopsy-market-3819
Key Takeaways of the GlobalSarcoma Biopsy Market:
The global sarcoma Biopsy marketis expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027),owing to increasing technological advancements in the field of biopsy.
Kaposi sarcoma being one of thesarcoma condition is much more common among men than women, and is rarelyobserved among children. For instance, according to the American Cancer Society(ACS), February 2016 data findings, around 1 in 200 transplant patients in theU.S. suffer from Kaposi sarcoma. In the U.S.
Major players operating in theglobal sarcoma biopsy market include R. Bard, Inc., Becton, Dickinson andCompany, Argon Medical Devices, InVivo Therapeutics Corporation, Cook MedicalIncorporated, UROMED, and Sterylab
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3819
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
